Find Clinical Trial

Home » Find Clinical Trials » SOTI and TROPOS phase III studies open-label extension. The long term efficacy and long term safety assessment of a five-year oral administration of strontium ranelate in osteoporotic postmenopausal women having participated either in Spinal Osteoporosis Therapeutic Intervention “SOTI” study or TReatment Of Peripheral OSteoporosis “TROPOS” study. A five-year multicentric multinational open study with strontium ranelate.

SOTI and TROPOS phase III studies open-label extension. The long term efficacy and long term safety assessment of a five-year oral administration of strontium ranelate in osteoporotic postmenopausal women having participated either in Spinal Osteoporosis Therapeutic Intervention “SOTI” study or TReatment Of Peripheral OSteoporosis “TROPOS” study. A five-year multicentric multinational open study with strontium ranelate.

← Back

Study Phase	Phase 3

Therapeutic Area	Rheumatology

Indication	Osteoporosis

Sponsor	Institut de Recherches Internationales Servier (I.R.I.S)

Active substance/ Medical device	STRONTIUM RANELATE, S012911

Active Substance Code	S012911

Protocol Code	CL3-12911-012

ISRCTN Code	ISRCTN48348637

Documents and links

Results summary	READ MORE

Scientific publication	READ MORE

Servier Glossary of Terms

To ease the reading, we are developing a glossary of terms. In this glossary, we provide the lay terms used in our lay summaries and the corresponding medical terms. You will find the Servier Glossary of Terms on this link.